Clinical Trials Update: Aug. 31, 2007
1816
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
521918
The new Genentech, Inc., cancer drug Avastin appears to extend survival for patients with colorectal cancer by nearly two months, US National Cancer Institute researchers have concluded.
281554
A U.S. advisory panel on Friday will  review data on an experimental drug that is injected into the  eye to stop vision loss in elderly patients at risk of going  blind.
62269
A New Jersey court awards damages to Idaho couple in Vioxx case.Plus: SEC and OSC file complaints against former Nortel execs... Bush administration says it's fish farming season... and more.
589264
Panacos releases more clinical trial results for an exciting drug.
696598
Two new trials have shown that a drug injected into the eye can effectively treat a potentially blinding form of age-related macular degeneration (AMD).
188930
GlaxoSmithKline's diabetes drug Avandia was not to blame for heart deaths in a trial to see if treating diabetes would reduce heart disease, U.S. government-funded researchers said on Wednesday.
52664
MONDAY, Oct. 18 (HealthDayNews) --The National Institute on Aging has launched a landmark study aimed at finding a way to use imaging technology to reduce the time and cost of clinical trials for Alzheimer's disease medications.
39604
Cancer patients treated with Genentech Inc.&#39;s colon cancer drug bevacizumab (Avastin) along with the chemotherapy regimen FOLFOX4 lived longer than patients treated with the chemotherapy alone in a late-stage clinical
743658
The U.S. Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.'s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
443950
October 1, 2004 5:11 PM GMT (Datamonitor) - The Food and Drug Administration (FDA) is set to examine the potential link between antidepressants and increased suicidal tendencies in adults.
643185
FRIDAY, Sept. 15 (HealthDay News) -- Researchers may be able to determine the effectiveness of anti-angiogenic cancer drugs by measuring levels of a type of blood cell.
153875
BOSTON, Oct. 29 /PRNewswire/ -- Data to be presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) demonstrated that treatment with the Bristol-Myers Squibb
606350
Abbott Laboratories filed a New Drug Application with the Food and Drug Administration for its drug Xinlay (atrasentan) to be used as a treatment for metastatic hormone-refractory prostate cancer.
266095
The pharmaceutical industry made a commitment Thursday to publish more data about clinical drug trials, amid growing questions about the safety of many leading companies' medicines.
548270
The findings of the 'American-Australian-African trial with DronedarONe In atrial fibrillation or flutter patients for the maintenance of Sinus rhythm' (ADONIS) trial, announced at the annual meeting of the ...
506148
It's running trials to see if the drug can be used in earlier stages of cancer.